Advertisement
Singapore markets closed
  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • Dow

    38,239.98
    +253.58 (+0.67%)
     
  • Nasdaq

    15,451.31
    +169.30 (+1.11%)
     
  • Bitcoin USD

    66,096.98
    +171.60 (+0.26%)
     
  • CMC Crypto 200

    1,421.26
    +6.50 (+0.46%)
     
  • FTSE 100

    8,050.24
    +26.37 (+0.33%)
     
  • Gold

    2,310.40
    -36.00 (-1.53%)
     
  • Crude Oil

    82.04
    +0.14 (+0.17%)
     
  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     
  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     
  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     
  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Moderna INC (MRNA) Q2 2020 Earnings Call Transcript

Moderna INC (MRNA) Q2 2020 Earnings Call Transcript

At this time, I'd like to turn the call over to Lavina Talukdar, head of investor relations at Moderna. Good morning, everyone, and welcome to Moderna's second-quarter 2020 conference call to discuss financial results and business update. On today's call are Stéphane Bancel, our chief executive officer; Tal Zaks, our chief medical officer; Stephen Hoge, our president; and David Meline, our chief financial officer.